<DOC>
	<DOC>NCT00855478</DOC>
	<brief_summary>To assess the safety and effecacy of the Cypher stent ™ &amp; Cypher Select ™ in the normal use of medical practices, within the labeled indications.</brief_summary>
	<brief_title>French Post-Marketing Surveillance Survey</brief_title>
	<detailed_description>Multi-center, retrospective and prospective French register. This register does not impose any constraint on the evaluated population, the procedure, or the required examinations. The local practice routines should be applied.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients with symptomatic ischemic heart disease due to de novo lesions (lesions &lt;30 mm vessel reference diameter of 2.25 mm to 5 mm), assessed visually, native coronary arteries. Patients suffering from coronary heart disease. Patients for whom treatment antiplatelet and / or anticoagulant is against the state; Patients with injuries incompatible with the full inflation of a balloon angioplasty; Transplant patients ; Patients with known allergy to Sirolimus, the stainless steel 316L, to polymethacrylates or copolymers polyolefins;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>